Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

Mario Mignini-Renzini,Claudio Brigante,Giovanni Coticchio,Mariabeatrice Dal Canto,Ilaria Caliari,Ruggero Comi,Elena De Ponti,Rubens Fadini

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

2017

Mario Mignini-Renzini
Claudio Brigante
Giovanni Coticchio
Mariabeatrice Dal Canto
Ilaria Caliari
Ruggero Comi
Elena De Ponti
Rubens Fadini

Purposes The aim of this study is to determine whether a clinical advantage is gained with use of LH in combination with FSH or as a component of human menopausal gonadotropin (hMG) to achieve optimal ovarian stimulation.

Keywords:

Internal medicine
Endocrinology
Biology
Ovarian reserve
Recombinant DNA
Gonadotropin
Pregnancy
HMG-CoA reductase
Stimulation
recombinant fsh
retrospective analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations